Resistell News:

Meet Resistell in Davos on 21.10.2021 at the 4th Swiss Symposium in Point-of-Care Diagnostics

Meet Resistell in Davos on 21.10.2021 at the 4th Swiss Symposium in Point-of-Care Diagnostics
Resistell News:

Meet Resistell in Davos on 21.10.2021 at the 4th Swiss Symposium in Point-of-Care Diagnostics

Meet Resistell's team at the Swiss Symposium in Point-of-Care Diagnostics and see live presentation of our technology.
Meet Resistell in Davos on 21.10.2021 at the 4th Swiss Symposium in Point-of-Care Diagnostics

Latest news

Resistell AG announces start of Performance Evaluation Study
16th June 2021

Resistell AG announces start of Performance Evaluation Study

Resistell AG has started the Performance Evaluation Study (PES) of its groundbreaking nanomotion technology at Lausanne University Hospital (CHUV)
Faster to the right antibiotic treatment - Resistell in Schweizerische Ärztezeitung
15th February 2021

Faster to the right antibiotic treatment - Resistell in Schweizerische Ärztezeitung

How do you find the most effective antibiotic for a patient as quickly as possible? The start-up "Resistell" has developed a new type of test for antibiotic resistance. Read more about this test in Schwizerische Ärztezeitung.
International Day of Women and Girls in Science - European Innovation Council interview with Danuta Cichocka
11th February 2021

International Day of Women and Girls in Science - European Innovation Council interview with Danuta Cichocka

On the International Day of Women and Girls in Science, European Innovation Council invited Danuta Cichocka, Resistell CEO, the female scientist and entrepreneur, to share her story about her passion in life science in an interview.
Aus welchem Holz sind Gründerinnen und Gründer geschnitzt?
10th February 2021

Aus welchem Holz sind Gründerinnen und Gründer geschnitzt?

Die Covid-Pandemie hat alle Bereiche des Lebens erfasst. Auch die Startup- und Gründerszene musste mit der Situation umgehen und unter erschwerten Bedingungen die Projekte weiter führen und antreiben. Gleichzeitig aber hat Corona als Katalysator gewirkt für disruptive Ideen, für Innovation und Unternehmergeist.
Venturelab's series about Switzerland’s most inspiring entrepreneurs and founders continues with Danuta Cichocka, the co-founder and CEO of Resistell AG.
7th January 2021

Venturelab's series about Switzerland’s most inspiring entrepreneurs and founders continues with Danuta Cichocka, the co-founder and CEO of Resistell AG.

The Muttenz-based biotech startup proposes an alternative to culture-based antibiograms, the current gold standard in antibiotic susceptibility testing. The EPFL spin-off offers a diagnostic device, the rapid AST method, which is based on the detection of movement caused by living bacterial cells. The new method reduces the time taken to get a result from days to minutes, shows which specific antibiotic is effective against the bacteria, and significantly improves the chances of patients’ survival.